99MTechnetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography

European Journal of Surgical Oncology

Volumn 33, Issue 1, 2007, Pages 23-27

  Gommans, G M M ^a,b   van der Zant, F M ^b   van Dongen, A ^a   Boer, R O ^a,b   Teule, G J J ^c   de Waard, J W D ^a  

^a WFG Hospital Hoorn   (Netherlands)

^b Location Alkmaar   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

99mTc sestamibi; Breast Cancer; Scintimammography

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PERTECHNETIC ACID TC 99M;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST CARCINOMA; BREAST SURGERY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG DISTRIBUTION; DRUG UPTAKE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE PROCESSING; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SCINTIMAMMOGRAPHY; SENSITIVITY AND SPECIFICITY;

AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MAMMOGRAPHY; MIDDLE AGED; PALPATION; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI;

EID: 33846362634     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.10.025     Document Type: Article

References (29)

1. Skaane P., Young K., and Skennald A. Population-based mammography screening: comparison of screen-film and full-field digital mammography with soft-copy reading-Oslo I study. Radiology 229 (2003) 877-884
2. Skaane P. Ultrasonography as adjunct to mammography in the evaluation of breast tumors. Acta Radiol Suppl 420 (1999) 1-47
3. Khalkhali I., Villanueva-Meyer J., Sl E., et al. Diagnostic accuracy of 99mTc-Sestamibi breast imaging: multi centre results. J Nucl Med 41 (2000) 1973-1079
4. Danielson R., Bone B., Gad A., Sylvan M., and Aspelin P. Sensitivity and specificity of planar scintimammography in the evaluation of breast lesions with 99mTc-sestamibi. Acta Radiol 40 (1999) 394-399
5. Taillefer R., Robidoux A., Lambert R., Turpin S., and Laperriere J. Technetium-99m-sestamibi to detect primary breast cancer and axillary lymph node involvement. J Nucl Med 36 (1995) 1758-1765
6. Mekhmandarov S., Sandbank J., Cohen M., Lelcuk S., and Lubin E. Technetium-99m-MIBI scintimammography in palpable and non-palpable lesions. J Nucl Med 86 (1998) 91
7. Danielson R., Reihner E., Grabowska A., and Bone B. The role of scintimammography with 99m-Tc-sestamibi as a complementary diagnostic technique in the detection of breast cancer. Acta Radiol 41 (2000) 441-445
8. Palmedo H., Biersack H.J., Lastoria S., et al. Scintimammography with technetium-99m-metoxyisobutylisonitrile: results of a prospective European multicentre trial. Eur J Nucl Med 25 (1998) 375-385
9. Lumachi F., Ferritti G., Povolato M., et al. Accuracy of technetium-99m sestamibi scintimammography and X-ray mammography in premenopausal women with suspected cancer. Eur J Nucl Med 28 (2001) 1776-1780
10. Lumachi F., Zucchetta P., Marzola M.C., et al. Positive predictive value of 99mTc sestamibi scintimammography in patients with non-palpable, mammographically detected, suspicious, breast lesions. Nucl Med Commun 23 (2002) 1073-2078
11. Buscombe J.R., Cwikla J.B., Holloway B., and Hilson A.J.W. Prediction of the usefulness of combined mammography and scintimammography in suspected primary breast cancer using ROC curves. J Nucl Med 42 (2001) 3-8
12. Wilczek B., Aspelin P., Bone B., Pergerfalk A., and Frisell J Danielsson R. Complementary use of scintimammography with 99m-Tc-MIBI to triple diagnosis procedure in palpable and non-palpable breast lesions. Acta Radiol 44 (2003) 288-293
13. Brem R.F., Schoonjans J.M., Kieper D.A., Majewski S., Goodman S., and Civelek C. High resolution scintimammography: a pilot study. J Nucl Med 43 (2002) 909-915
14. Leidenius M.H.K., Leppänen E.A., Tykkä, and van Smitten K.A.J. The role of Tc99m-sestamibi scintimammography in combination with the tripple assessment op primary breast cancer. EJSO 28 (2002) 108-112
15. Bombardieri E., Aktolun C., Baum R.P., et al. Breast scintigraphy: procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging 30 (2003) BP107-BP114
16. Bone B., Wiberg M.K., Szabo B.K., Szakos A., and Danielsson R. Comparison of 99mTc-sestamibi scintimammography and dynamic MR imaging as adjuncts to mammography in the diagnosis of breast cancer. Acta Radiol 44 (2003) 28-34
17. Tiling R., Sommer H., Pechmann M., et al. Comparison of technetium-99m sestamibi scintimammography with contrast-enhanced MRI for diagnosis of breast lesions. J Nucl Med 38 (1997) 58-62
18. Fondrinier E., Muratet J.P., Anglade E., et al. Clinical experience with 99mTc-MIBI scintimammography in patients with breast microcalcifications. Breast 13 4 (2004) 316-320
19. Papantoniou V., Tsiouris S., Mainta E., et al. Imaging in situ breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography. Breast Cancer Res 7 1 (2005) R33-R45
20. Wang H.C., Sun S.S., Kao A., Lin C.C., and Lee C.C. Comparison of technetium-99m methoxyisobutylisonitrile scintimammography and ultrasonography in the diagnosis of breast cancer in patients with mammagraphically dense breast. Cancer Invest 20 (2002) 318-323
21. Mathieu I., Mazy S., Willemart B., Destine M., Mazy G., and Lonneux M. Inconclusive triple diagnosis in breast cancer imaging: is there a place for scintimammography?. J Nucl Med 46 10 (2005) 1574-1581
22. Myslivecek M., Koranda P., Kaminek M., et al. Technetium-99m-Mibi scintimammography by planar and SPECT imaging in the diagnosis of breast carcinoma and axillary lymph node involvement. Nucl Med Rev Cent East Eur 7 2 (2004) 151-155
23. Mulero F., Nicolas F., Castellon M.I., Claver M.A., and Abad L. Nuno de la Rosa JA. Scintigraphy with 99mTc-MIBI in the diagnosis of axillary lymph node invasion of breast cancer. Rev Esp Med Nucl 19 (2000) 416-422
24. Sapino A., Cassoni P., Zanon E., et al. Ultrasonographically-guided fine-needle aspiration of axillary lymph nodes: role in breast cancer management. Br J Cancer 88 (2003) 702-706
25. Pedrosian I., Bedi D., Kuerer H.M., et al. Impact of clinicopathological factors on sensitivity of axillary ultrasonography in the detection of axillary nodal metastases in patients with breast cancer. Ann Surg Oncol 10 (2003) 1025-1030
26. Koukouraki S., Koukourakis M.I., Vagios E., Velidaki A., Tsiftsis D., and Karkavitsas N. The role of 99m Tc-sestamibi scintimammography and colour Doppler ultrasonography in the evaluation of breast lesions. Nucl Med Commun 22 (2001) 1243-1248
27. Bagni B., Francesschetto A., Casolo A., et al. Scintimammography with 99mTc-MIBI and magnetic resonance imaging in the evaluation of breast cancer. Eur J Nucl Med Mol Imaging 30 (2003) 1383-1388
28. Tiling R., Linke R., Untch M., et al. 18F-FDG PET and 99mTc-sestamibi scintimammography for monitoring breast cancer response to neoadjuvant chemotherapy: a comparative study. Eur J Nucl Med 28 (2001) 711-720
29. Danielson R., Bone B., Perbeck L., and Aspelin P. Evaluation of planar scintimammography with 99m Tc-MIBI in the detection of axillary lymph node metastasis of breast carcinoma. Acta Radiol 40 (1999) 491-495